Showing 791-800 of 7651 results for "".
DermWireTV: Doximity Physician Compensation Report, EADV Updates, PsO in the Know
https://practicaldermatology.com/topics/psoriasis/dermwiretv-doximity-physician-compensation-report-eadv-updates-pso-in-the-know/19870/Doximity’s fourth annual Physician Compensation Report shows a widening of the gender pay gap. From biologics and investigational molecules for psoriasis to socks to prevent foot odors, the European Academy of Dermatology and Venereology annual meeting highlights emerging therapies for dermatology pBeyond Telehealth: Three Ways Dermatology Is Going Digital in the Wake of Coronavirus
https://practicaldermatology.com/topics/practice-management/beyond-telehealth-three-ways-dermatology-is-going-digital-in-the-wake-of-coronavirus/23368/These digital opportunities can set your practice apart from the competition.DermWireTV: Clinical Support Tech Data; Dupixent, Stelara Updates; Rihanna Launches Fenty Skin
https://practicaldermatology.com/topics/psoriasis/dermwiretv-clinical-support-tech-data-dupixent-stelara-updates-rihanna-launches-fenty-skin/19835/A feasibility study in collaboration between LEO Innovation Lab, VisualDX, and the German Association of Dermatological Prevention supports technology to assist in diagnosis of skin conditions. Leo Pharma’s investigational JAK inhibitor delgocitinib cream is Fast Tracked by the FDA for the potentiaCrisis Management: Office Operations, Part 1
https://practicaldermatology.com/topics/practice-management/crisis-management-office-operations-part-1/18181/How are primarily cosmetic dermatology practices dealing with shutdowns and preparing for the future? Host Neal Bhatia, MD discusses with Deirdre Hooper, MD, Ashish Bhatia, MD, Kevin Pinski, MD, and Nancy Samolitis, MD.In the Mind of Today’s Cosmetic Consumer
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/in-the-mind-of-todays-cosmetic-consumer/23102/Who is your cosmetic patient and how will they interact with your practice? Experts weigh in.Antibiotics and Cosmetic Trends; Seysara Launches
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-antibiotics-and-cosmetics-trends-seysara-launches/19532/Dermatologists are prescribing fewer antibiotics to manage acne and rosacea. But, the use of antibiotics after surgical procedures is on the rise. More than one third of American adults are considering a cosmetic treatment in 2019, results of a RealSelf survey show. Seysara (sarecycline), a novel teEvent Marketing: Strategies to Spotlight Your Practice and Cosmetic Services
https://practicaldermatology.com/topics/practice-management/event-marketing-strategies-to-spotlight-your-practice-and-cosmetic-services/20335/The notion of hosting an event can be overwhelming, but many practices find the endeavor worthwhile. Ahead are tips for success—and a word of caution.Biosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.Inside Cosmeceutical Marketing Claims
https://practicaldermatology.com/topics/general-topics/inside-cosmeceutical-marketing-claims/21642/Dermatologists and their patients may wonder what makes a product “dermatologist tested” or “clinically proven.” Here's what you need to know.Are We Overlooking Skin Cancer in Ethnic Minorities?
https://practicaldermatology.com/issues/supplements/are-we-overlooking-skin-cancer-in-ethnic-minorities/21718/Skin cancers in Hispanic and African American patients may be detected at more advanced stages, leading to poorer prognoses and long-term outcomes compared to non-Hispanic whites.